top of page

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Fennec Pharmaceuticals Inc. - Common Stock (NQ:FENC)

6.200 -0.310 (-4.76%)

Streaming Delayed Price Updated: 12:03 PM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Fennec Pharmaceuticals Inc. - Common Stock

< Previous 1 2 Next >

Fennec Pharmaceuticals (NASDAQ:FENC) Reports Q4 2025 Revenue Growth but Misses Earnings Estimates ↗

March 24, 2026

Via Chartmill

Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year ↗

March 15, 2026

This water solutions provider serves both consumers and businesses through recurring sales and a broad portfolio of regional brands.

Via The Motley Fool

Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue ↗

March 15, 2026

Euronet Worldwide runs a global payments platform, providing transaction processing and money transfer solutions across diverse markets.

Via The Motley Fool

Solas Capital Loads Up On Kyndryl With 407,000 Shares Bought ↗

March 05, 2026

This technology firm delivers IT infrastructure and managed solutions to major enterprises across multiple global industries.

Via The Motley Fool

Topics Artificial Intelligence

Earnings Scheduled For August 14, 2025 ↗

August 14, 2025

Via Benzinga

Fennec Pharmaceuticals Earnings Preview ↗

August 13, 2025

Via Benzinga

Fennec Pharmaceuticals's Earnings Outlook ↗

March 20, 2024

Via Benzinga

Fennec Q2 Sales Jump 33 Percent ↗

August 14, 2025

Via The Motley Fool

Fennec (FENC) Q2 2025 Earnings Call Transcript ↗

August 14, 2025

Via The Motley Fool

Topics Earnings Intellectual Property

Fennec Pharmaceuticals Inc (NASDAQ:FENC) Reports Mixed Q2 2025 Earnings with Revenue Slight Miss and Wider-Than-Expected Loss ↗

August 14, 2025

Fennec Pharmaceuticals reported mixed Q2 2025 results, missing revenue estimates by 0.6% and posting a wider EPS loss. PEDMARK® growth and new accounts drove optimism despite financial...

Via Chartmill

Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday? ↗

March 10, 2025

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir...

Via Benzinga

Topics Economy Stocks

Earnings Scheduled For November 6, 2023 ↗

November 06, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.

Via Benzinga

Preview: Fennec Pharmaceuticals's Earnings ↗

November 03, 2023

Via Benzinga

Analyst Ratings for Fennec Pharmaceuticals ↗

June 21, 2023

Via Benzinga

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

Earnings Scheduled For March 10, 2025 ↗

March 10, 2025

Via Benzinga

Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗

February 10, 2025

Via Benzinga

FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 ↗

August 13, 2024

FENC stock results show that Fennec Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

Recap: Fennec Pharmaceuticals Q1 Earnings ↗

May 11, 2023

Via Benzinga

Earnings Outlook For Fennec Pharmaceuticals ↗

May 10, 2023

Via Benzinga

Analyst Ratings for Fennec Pharmaceuticals ↗

April 06, 2023

Via Benzinga

3 Dirt-Cheap Stocks Under $10 That Could EXPLODE! ↗

July 29, 2024

These dirt cheap stocks under $10 have the potential to rise rapidly and create fortunes for bold investors.

Via InvestorPlace

Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 14, 2024

Via Benzinga

FENC Stock Earnings: Fennec Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 ↗

May 14, 2024

FENC stock results show that Fennec Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Expert Ratings for Fennec Pharmaceuticals ↗

November 22, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About Fennec Pharmaceuticals ↗

November 22, 2022

Via Benzinga

FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023 ↗

March 21, 2024

FENC stock results show that Fennec Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Earnings Scheduled For March 21, 2024 ↗

March 21, 2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.

Via Benzinga

7 Biotech Stocks Sitting in the Sweet Spot ↗

March 24, 2023

Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable.

Via InvestorPlace

US Stocks Open Lower; Dow Dips 250 Points ↗

January 25, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.74% to 33,484.47 while the NASDAQ fell...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

220 S. Main St.
Colville, WA 99114

Hours: Mon.-Fri., 8 a.m.-5 p.m.

509-684-4567
editor@statesmanexaminer.com

Site by Amber S. King – Creative Design

Home
About
Contact
Submissions

bottom of page